Università LUM Giuseppe Degennaro - sito della Ricerca Institutional Research Information System

CACCIAPAGLIA, FABIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.512
SA - Sud America 1.091
NA - Nord America 812
EU - Europa 220
AF - Africa 148
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 3.787
Salva come PNG Salva come JPEG
Nazione #
BR - Brasile 845
US - Stati Uniti d'America 759
VN - Vietnam 538
SG - Singapore 414
CN - Cina 338
AR - Argentina 104
MA - Marocco 99
IT - Italia 51
EC - Ecuador 49
ID - Indonesia 45
HK - Hong Kong 41
FR - Francia 29
PK - Pakistan 29
CO - Colombia 28
BD - Bangladesh 27
RU - Federazione Russa 24
DE - Germania 22
MX - Messico 22
PY - Paraguay 22
ZA - Sudafrica 22
GB - Regno Unito 18
UA - Ucraina 16
IN - India 13
IQ - Iraq 12
NL - Olanda 12
PL - Polonia 12
CA - Canada 11
CL - Cile 11
PE - Perù 10
UY - Uruguay 10
VE - Venezuela 10
EG - Egitto 8
AT - Austria 7
SY - Repubblica araba siriana 7
AZ - Azerbaigian 5
GT - Guatemala 5
NP - Nepal 5
SE - Svezia 5
UZ - Uzbekistan 5
DO - Repubblica Dominicana 4
KZ - Kazakistan 4
TN - Tunisia 4
TR - Turchia 4
CG - Congo 3
HN - Honduras 3
IE - Irlanda 3
KE - Kenya 3
KG - Kirghizistan 3
XK - ???statistics.table.value.countryCode.XK??? 3
AO - Angola 2
BG - Bulgaria 2
BN - Brunei Darussalam 2
BO - Bolivia 2
BY - Bielorussia 2
CH - Svizzera 2
DZ - Algeria 2
ES - Italia 2
FI - Finlandia 2
IR - Iran 2
JO - Giordania 2
JP - Giappone 2
LB - Libano 2
LK - Sri Lanka 2
LT - Lituania 2
OM - Oman 2
PA - Panama 2
PH - Filippine 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SV - El Salvador 2
AL - Albania 1
AU - Australia 1
BW - Botswana 1
CR - Costa Rica 1
CY - Cipro 1
EE - Estonia 1
HR - Croazia 1
IL - Israele 1
IM - Isola di Man 1
JM - Giamaica 1
KW - Kuwait 1
ML - Mali 1
MT - Malta 1
MU - Mauritius 1
NI - Nicaragua 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
TT - Trinidad e Tobago 1
Totale 3.787
Salva come PNG Salva come JPEG
Città #
Dallas 285
Singapore 199
Ho Chi Minh City 197
Ashburn 115
Hanoi 106
Hefei 104
Casablanca 93
The Dalles 81
São Paulo 67
San Jose 50
Hong Kong 41
Rio de Janeiro 30
Da Nang 26
Islamabad 26
Boydton 25
Beijing 23
Hillsboro 23
Hải Dương 18
Guayaquil 17
Haiphong 17
Curitiba 16
Biên Hòa 14
Quito 14
Ribeirão Preto 13
Thái Bình 13
New York 12
Warsaw 12
Porto Alegre 11
Teresina 11
Brasília 10
Can Tho 9
Chicago 9
Fortaleza 9
Lấp Vò 9
Rio Bonito 9
Sorocaba 9
Frankfurt am Main 8
Los Angeles 8
Montevideo 8
Phủ Lý 8
Salvador 8
Viamão 8
Asunción 7
Atibaia 7
Bari 7
Belo Horizonte 7
Campinas 7
Goiânia 7
Johannesburg 7
Ninh Bình 7
Pelotas 7
Rome 7
Avellaneda 6
Bogotá 6
Bắc Ninh 6
Feira de Santana 6
Guarulhos 6
Manaus 6
Milan 6
Naucalpan 6
Orem 6
Quảng Ngãi 6
Santa Clara 6
Thái Nguyên 6
Amsterdam 5
Baghdad 5
Barnet 5
Buenos Aires 5
Bắc Giang 5
Cape Town 5
Dhaka 5
Jakarta 5
Lima 5
Limburg an der Lahn 5
Ourinhos 5
Pindamonhangaba 5
Santiago de Cali 5
Santo André 5
St Petersburg 5
Vĩnh Tường 5
Bauru 4
Brooklyn 4
Cairo 4
Caracas 4
Catania 4
Chennai 4
Concepción 4
Cuenca 4
Gravatá do Ibiapina 4
Ha Long 4
Hortolândia 4
Huế 4
Itabaiana 4
Itaquaquecetuba 4
João Pessoa 4
Kathmandu 4
Mexico City 4
Natal 4
Nova Iguaçu 4
Petrolina 4
Totale 2.073
Salva come PNG Salva come JPEG
Nome #
Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort 56
Systemic syndromes of rheumatological interest with onset after COVID-19 vaccine administration: a report of 30 cases 55
Comparison of Adalimumab to Other Targeted Therapies in Rheumatoid Arthritis: Results from Systematic Literature Review and Meta-Analysis 55
Atherosclerosis and Autoimmunity 54
Adherence to the 2019 ESC/EAS guidelines for dyslipidaemia management in a large rheumatoid arthritis cohort: Data from the CORDIS Study Group of the Italian Society of Rheumatology 53
Clinical Features of Diabetes Mellitus on Rheumatoid Arthritis: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group 52
Apoptotic molecular mechanisms implicated in autoimmune diseases 51
Comorbid fibromyalgia impairs the effectiveness of biologic drugs in patients with psoriatic arthritis 50
APOPTOSIS AND AUTOIMMUNITY INDUCED BY CLODRONATE IN SYSTEMIC LUPUS ERYTHEMATOSUS MONONUCLEAR CIRCULATING CELLS 49
Complete Hydatidiform Mole Mimicking Sacroiliitis 48
Rituximab retention rate in systemic sclerosis: a long term real-life multicenter study 48
Alexithymia and neuroendocrine-immune response in patients with autoimmune diseases: preliminary results on relationship between alexithymic construct and TNF-alpha levels 45
Influence of TNF-alpha inhibition on oxidative stress of rheumatoid arthritis patients 45
Cardiovascular safety of anti-TNF-alpha therapies: Facts and unsettled issues 45
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments. 45
Antinuclear antibodies prevalence in Filipinos migrated to Italy 44
COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity 44
The adjunctive role of antiphospholipid antibodies in systemic lupus erythematosus cardiac involvement 44
Spontaneous splenorenal shunt in a patient with antiphospholipid syndrome: the first case reported 44
Practice pattern for the use of intravenous iloprost for the treatment of peripheral vasculopathy in systemic sclerosis: A case-control study from the Italian national multicenter "SPRING" (Systemic Sclerosis Progression InvestiGation) Registry 44
Body mass index and adipokines/cytokines dysregulation in systemic sclerosis 44
Broad clinical spectrum of SARS-CoV-2-associated inflammatory joint disease in adults: a report of 35 cases from the COVID-19 & Autoimmune Systemic Disease Italian study group. 43
Long-term retention rate, adverse event temporal patterns and rescue treatment strategies of mycophenolate mofetil in systemic sclerosis: insights from real-life 43
Stiffness parameters, intima-media thickness and early atherosclerosis in systemic lupus erythematosus patients 42
A Machine Learning Approach for Predicting Sustained Remission in Rheumatoid Arthritis Patients on Biologic Agents 42
Effectiveness of tapering rituximab dose in idiopathic inflammatory myopathies: Real-world data from a monocentric study 42
The natural history of insulin content in the pancreas of female and mate non-obese diabetic mouse: implications for trials of diabetes prevention in humans 42
Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases 42
Cardiovascular risk estimation with 5 different algorithms before and after 5 years of bDMARD treatment in rheumatoid arthritis 42
Traditional and non traditional risk factors in accelerated atherosclerosis in Systemic Lupus Erythematosus: Role of vascular endothelial growth factor (VEGATS Study) 41
Effectiveness of biological targeted therapies may discriminate seronegative from seropositive rheumatoid arthritis 41
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups 41
Inflammation and iron metabolism in adult patients with epilepsy: Does a link exist? 40
Serum adiponectin levels are associated with presence of carotid plaque in women with systemic lupus erythematosus. 39
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase 39
Lipid Profile of Rheumatoid Arthritis Patients Treated with Anti-Tumor Necrosis Factor-Alpha Drugs Changes According to Disease Activity and Predicts Clinical Response 39
Effects of cytotoxic T-lymphocyte-associated protein 4 compared to TNF inhibitors on lipid profile: Results from an observational multicentre rheumatoid arthritis cohort 39
Italian recommendations for the assessment of cardiovascular risk in rheumatoid arthritis: a position paper of the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group of the Italian Society for Rheumatology 39
Plasma pentraxin 3 in idiopathic inflammatory myopathies: a possible new biomarker of disease activity 38
Serum sCD40L levels are increased in patients with psoriatic arthritis and are associated with clinical response to apremilast. 38
Postmeal portal flow variations in HCV-related chronic hepatitis and liver cirrhosis with and without hyperdynamic syndrome 38
Safety and effectiveness in switching from reference to biosimilar rituximab in rheumatoid arthritis patients: real world experience from a single Italian rheumatology centre 38
Sex Differences in Cardiovascular Risk Profiles of Patients with Rheumatoid Arthritis: Results from an Italian Multicentre Cohort 38
Percutaneous ultrasound-guided ablation of BW7756-hepatoma using ethanol or acetic acid in a rat model 38
Systemic sclerosis Progression INvestiGation (SPRING) Italian registry: demographic and clinico-serological features of the scleroderma spectrum. 37
Response to: "Influence of changes in cholesterol levels and disease activity on the 10-year cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients" by Fornaro et al' by Agca et al 37
The adjunctive role of antiphospholipid antibodies in systemic lupus erythematosus cardiac involvement 37
Janus kinase inhibitors: between prescription authorization and reimbursability 37
Adipokines and Systemic Lupus Erythematosus: Relationship with Metabolic Syndrome and Cardiovascular Disease Risk Factors 37
A Bayesian mixed treatment comparison of efficacy of biologics and small molecules in early rheumatoid arthritis 37
Possible role of adipocytokines in systemic sclerosis-associated small pericardial effusion 37
Lack of effect of vitamin D administration during pregnancy and early life on diabetes incidence in the non-obese diabetic mouse 37
Tumour necrosis factor alpha (TNFα) cardiomyocyte preconditioning: Clues to explain anti-TNFα agents contraindication in severe heart failure 36
COVID-19 vaccine immunogenicity in 16 patients with autoimmune systemic diseases. Lack of both humoral and cellular response to booster dose and ongoing disease modifying therapies 36
Pulmonary and extra-pulmonary effects of lung transplantation in an Italian cohort of patients with systemic sclerosis 36
Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology 36
Golimumab in real-life settings: 2 Years drug survival and predictors of clinical outcomes in rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis 36
Tomographic regression of pulmonary rheumatoid nodules under baricitinib therapy 36
Anti-TNF treatment response in rheumatoid arthritis patients with moderate disease activity: a prospective observational multicentre study (MODERATE) 36
Disease activity assessment for juvenile idiopathic arthritis in transitional care 35
Towards a comprehensive approach to the management and prognosis of systemic sclerosis's patients: The role of comorbidities in the SPRING-SIR registry 35
Efficacy of baricitinib on refractory skin papulosquamous rash in a patient with systemic lupus erythematosus 35
Prevalence and death rate of COVID-19 in systemic autoimmune diseases in the first three pandemic waves. Relationship to disease subgroups and ongoing therapies 35
The Impact of Biologic Drugs on High-Density Lipoprotein Cholesterol Efflux Capacity in Rheumatoid Arthritis Patients. 34
Immunogenicity of BNT162b2 mRNA SARS-CoV-2 vaccine in patients with psoriatic arthritis on TNF inhibitors 34
C-reactive protein and 10-year cardiovascular risk in rheumatoid arthritis 34
Matters of the Heart: The Case of TNF alpha-Targeting Drugs 34
Effective tumour necrosis factor-blocking therapy reduces reactive oxygen metabolite level in rheumatoid arthritis 34
Survival and Prognostic factors from a multicentre large cohort of unselected Italian Systemic Sclerosis patients 34
Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group 33
IL TUTORATO D'AULA 33
Lack of effect of vitamin D administration during pregnancy and early life on diabetes incidence in the non-obese diabetic mouse 33
Leptin, adiponectin and vascular stiffness parameters in women with systemic lupus erythematosus 33
Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey 33
The use of a glucose spray device to control progression towards hypoglycaemia 33
Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry 'SPRING' of the Italian Society for Rheumatology 33
The natural history of insulin content in the pancreas of female and male non-obese diabetic mouse: implication for trials of diabetes prevention in humans 32
Psoriatic arthritis and obesity: the role of anti-IL-12/IL-23 treatment 32
Lipids and Atherogenic Indices Fluctuation in Rheumatoid Arthritis Patients on Long-Term Tocilizumab Treatment 32
Portosystemic shunts in a large cohort of patients with liver cirrhosis: detection rate and clinical relevance 32
Predictors of long-term clinical remission in rheumatoid arthritis 32
Pulmonary arterial hypertension: guidelines and unmet clinical needs. 32
Endothelial dysfunction and activation as an expression of disease: role of prostacyclin analogs 31
Response to: 'Response to: "Influence of changes in cholesterol levels and disease activity on the 10-year cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients" by Fornaro et al' by Agca et al. 31
Splenic Infarction as Only Manifestation of Antiphospholipid Syndrome in a Patient With Rheumatoid Arthritis 30
Endothelial dysfunction and activation as an expression of disease: role of prostacyclin analogs 30
Serum osteopontin negatively impacts on intima-media thickness in patients with systemic lupus erythematosus 30
Thoracic lymphadenopathy as possible predictor of the onset of interstitial lung disease in systemic sclerosis patients without lung involvement at baseline visit: A retrospective analysis 30
Incidence and risk factors for gangrene in patients with systemic sclerosis from the EUSTAR cohort 30
High disease relapse after bDMARD spacing in psoriatic arthritis compared to rheumatoid arthritis and axial spondyloarthritis patients: real-life data from BIOPURE registry. 30
Golimumab effectiveness in biologic inadequate responding patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis in real-life from the Italian registry GISEA. 29
Varicella-zoster virus infection in rheumatoid arthritis patients in the anti-tumour necrosis factor era 29
Phosphorylated signal transducer and activator of transcription 3 (pSTAT3) is highly expressed in CD14+ circulating cells of scleroderma patients 29
The Use of an Interferon-Gamma Release Assay as a Biomarker of Response to Anti-TNF-Alpha Treatment 29
Successful treatment with anakinra of refractory pericarditis in systemic lupus erythematosus 29
Low Level Tumor Necrosis Factor-Alpha Protects Cardiomyocytes Against High Level Tumor Necrosis Factor-Alpha: Brief Insight into a Beneficial Paradox 28
Subcutaneous immunoglobulin therapy for refractory skin thickening in rapidly progressive systemic sclerosis: A case report and literature review 27
Safety profile and low risk of disease relapse after BNT162b2 mRNA SARS-COV-2 vaccination in patients with rare rheumatic diseases 27
Long-term safety of rituximab in rheumatic patients with previously resolved hepatitis B virus infection 25
New technologies aiding dietary programmes for weight control: the oral glucose spray 25
Totale 3.773
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.134
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.134
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025462 0 0 0 120 24 97 28 17 46 24 77 29
2025/20263.443 47 312 775 1.368 73 51 202 255 103 152 65 40
2026/20275 5 0 0 0 0 0 0 0 0 0 0 0
Totale 3.910